CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 36 enrolled
Drug / intervention
Sodium fluoride +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01128972
NCT01128972Phase 2Completed

Evaluation of a Test Mouthwash and Dentifrice Regimen in an In-situ Model of Dental Erosion

GlaxoSmithKline·interventional·Posted May 24, 2010·Updated Jan 1, 2015

In Brief

A Phase 2 clinical trial evaluating Sodium fluoride, Sodium monoflurophosphate, and 1 other intervention for Tooth Erosion. Completed, enrolled 36 participants across 1 site.

Detailed Summary

An in situ model will be used to evaluate and compare enamel remineralization of bovine enamel specimens.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTooth Erosion
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 24, 2010
Enrollment StartAug 1, 2009
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.1 years ago

Interventions

Sodium fluoridedrug

Test fluoride toothpaste and test fluoride mouth rinse

Sodium monoflurophosphatedrug

United Kingdom marketed fluoride toothpaste

Sterile waterdrug

Sterile water rinse